GAS6 and intestinal neoplasm: In conclusion, Gas6/TAM signaling has been demonstrated to reduce local immune inflammatory responses through the mechanisms outlined above, exert potential intestinal tumor suppression, and prolong the survival of colorectal cancer patients.